George Magrath - 01 Nov 2023 Form 3 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: Chief Executive Officer
Signature: /s/ Stephanie Swan, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 01 Nov 2023
Net transactions value: $0
Form type: 3
Filing time: 03 Nov 2023, 09:22:44 UTC
Next filing: 20 Mar 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24, Power of Attorney, is attached.